ERBB2 and breast cancer: Like PEAK1, elevated SNAI2 expression in HER2-positive breast cancer predicts reduced RFS (Fig. 1n, o) as well as DMFS (Supplementary Fig. 3a) in HER2-positive breast cancer – patterns also observed for fibronectin in this same cancer subset (Supplementary Fig. 3c).